WST

WST Net Receivables

$712.00MQuarterly · USD

Period ending:

WST FY Net ReceivablesUSD
WST FY Net Receivables1985-12-31: $23.30M1986-12-31: $33.40M1987-12-31: $35.40M1988-12-31: $44.10M1989-12-31: $44.00M1990-12-31: $41.80M1991-12-31: $42.80M1992-12-31: $41.90M1993-12-31: $43.30M1994-12-31: $57.80M1995-12-31: $67.90M1996-12-31: $69.30M1997-12-31: $60.40M1998-12-31: $64.40M1999-12-31: $74.60M2000-12-31: $60.90M2001-12-31: $61.80M2002-12-31: $66.60M2003-12-31: $114.50M2004-12-31: $75.10M2005-12-31: $110.50M2006-12-31: $110.50M2007-12-31: $136.10M2008-12-31: $128.60M2009-12-31: $138.70M2010-12-31: $126.40M2011-12-31: $147.20M2012-12-31: $175.00M2013-12-31: $185.70M2014-12-31: $179.00M2015-12-31: $181.40M2016-12-31: $200.50M2017-12-31: $253.20M2018-12-31: $288.20M2019-12-31: $319.30M2020-12-31: $385.30M2021-12-31: $489.00M2022-12-31: $507.40M2023-12-31: $512.00M2024-12-31: $552.50M2025-12-31: $574.40M$574.40M$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

WST net receivables history

Net amount expected from customer receivables. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

West Pharmaceutical Services Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)
574,400,000
552,500,000
512,000,000
507,400,000
489,000,000
385,300,000
319,300,000
288,200,000
253,200,000
200,500,000
181,400,000
179,000,000
185,700,000
175,000,000
147,200,000
126,400,000
138,700,000
128,600,000
136,100,000
110,500,000
110,500,000
75,100,000
114,500,000
66,600,000
61,800,000
60,900,000
74,600,000
64,400,000
60,400,000
69,300,000
67,900,000
57,800,000
43,300,000
41,900,000
42,800,000
41,800,000
44,000,000
44,100,000
35,400,000
33,400,000
23,300,000

Compare net receivables

All WST financial metrics · WST stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.